文献速递骨肌技术与安全MR

乳腺癌、前列腺癌及骨髓瘤恶性骨病灶的相对脂肪分数显著低于正常骨髓且观察者间一致性极佳

Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement.
PubMed 文献 · Br J Radiol · 2023-10-31

回顾性分析110例乳腺癌(n=26)、骨髓瘤(n=32)和前列腺癌(n=52)患者的全身MRI相对脂肪分数(rFF)图,由两名放射科医生测量恶性骨病灶与正常骨髓的rFF。恶性骨病灶中位rFF为13.87%,显著低于正常骨髓的89.76%(p<0.0001),不同恶性肿瘤及解剖部位间无显著差异,观察者间一致性极佳(0.95)。作者认为低rFF提供的高图像对比可能用于检测骨转移。

要点

  • 恶性骨病灶中位rFF为13.87%,正常骨髓为89.76%,两者重叠很少(p<0.0001)。
  • 乳腺癌、骨髓瘤和前列腺癌骨病灶的中位rFF分别为14.46%、13.12%和13.67%,组间无显著差异。
  • rFF测量的观察者间一致性极佳,组内相关系数为0.95。

核心结论

  • 乳腺癌、前列腺癌和骨髓瘤的活跃骨病灶rFF低,相对于正常骨髓提供高图像对比,可能用于检测骨转移。

研究设计与样本

  • 回顾性评估乳腺癌(n=26)、骨髓瘤(n=32)和前列腺癌(n=52)患者,两名放射科医生审阅110幅全身MRI基线rFF图。

关键影像表现/征象

  • 恶性骨病灶中位rFF为13.87%,正常骨髓为89.76%,两者重叠很少(p<0.0001)。
  • 乳腺癌、骨髓瘤和前列腺癌骨病灶的中位rFF分别为14.46%、13.12%和13.67%,组间无显著差异(p>0.017,Bonferroni校正)。
  • 不同解剖部位骨病灶的中位rFF无显著差异(p>0.008,Bonferroni校正)。

诊断标准与关键数值

  • 恶性骨病灶中位rFF 13.87% vs 正常骨髓89.76%(p<0.0001)。
  • 乳腺癌骨病灶中位rFF 14.46% vs 骨髓瘤13.12% vs 前列腺癌13.67%(p>0.017,Bonferroni校正)。
  • 观察者间一致性组内相关系数为0.95。

临床应用与阅片要点

  • 每位患者最多选取4个焦点活跃病灶绘制感兴趣区,分别位于颈胸椎、腰骶椎、骨盆和四肢各一个。
  • 无弥漫性骨病的患者(n=88)在骨盆测量正常骨髓rFF。
  • 作者认为低rFF提供的图像对比可能用于检测骨转移。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare relative fat fraction (rFF) of active bone lesions from breast, prostate and myeloma malignancies and normal bone marrow; to assess its inter-reader agreement.

METHODS: Patients with breast (n = 26), myeloma (n = 32) and prostate cancer (n = 52) were retrospectively evaluated. 110 baseline rFF maps from whole-body MRI were reviewed by two radiologists. Regions of interest for up to four focal active lesions in each patient were drawn on rFF maps, one each at the cervicothoracic spine, lumbosacral spine, pelvis and extremity. The mean and standard deviation of rFF were recorded. The rFF of normal marrow was measured in the pelvis for patients without diffuse bone disease (n = 88). We compared the rFF of malignant bone lesions and normal marrow using Mann-Whitney test. Interobserver agreement was assessed by interclass correlation coefficient.

RESULTS: Malignant bone lesions showed significantly lower median rFF (13.87%) compared with normal marrow (89.76%) with little overlap (p < 0.0001). There was no significant difference in the median rFF of malignant lesions from breast (14.46%), myeloma (13.12%) and prostate cancer (13.67%) (p > 0.017, Bonferroni correction) and in the median rFF of bone disease according to their anatomical locations (p > 0.008, Bonferroni correction). There was excellent interobserver agreement (0.95).

CONCLUSION: The low rFF of active bone lesions in breast, prostate and myeloma malignancies provides high image contrast relative to normal marrow that may be used to detect bone metastases.

ADVANCES IN KNOWLEDGE: This study shows the importance of rFF towards detecting bone metastases.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Castagnoli F, Donners R, Tunariu N, et al. Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement. Br J Radiol. 2023. PMID: 37750943. doi:10.1259/bjr.20230240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。